Clinuvel Pharmaceuticals 's market cap is currently $398.61M. The company's EPS TTM is $0.28711478; its P/E ratio is 18.38; and it has a dividend yield of 0.38%. Clinuvel Pharmaceuticals is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is $0.17. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25
Dec 24
Dec 23
Dec 22
Dec 21
Currency in AUD
Clinuvel Pharmaceuticals Earnings and Revenue History
